Redefining medical cannabis delivery in australia
CondensaMed is an Australian medical technology venture developing a first-of-its-kind handheld inhalation platform for medical cannabis. We address the clinical, safety, and usability limitations of existing methods, offering controlled, consistent, and patient-centred inhalation within a regulated medical framework. Discover how we're setting a new standard for care.
Solving the puzzle of precise dosing
Medical cannabis shows immense promise, yet current delivery methods force patients to choose between slow, imprecise dosing or harmful respiratory exposure. This makes consistent therapeutic effects challenging. CondensaMed delivers precise, controlled doses in a safer, more consistent way, bridging the gap between efficacy and safety. Patients seeking rapid, accurate relief, clinicians needing predictable therapies, researchers, and healthcare systems all benefit from our innovative approach, ensuring patients get the relief they need with the consistency clinicians require and the safety patients deserve.
A new standard in medical cannabis care
Most medical cannabis delivery options offer a compromise: slow, unpredictable dosing or inhalation methods with harmful combustion byproducts. CondensaMed changes the game by combining rapid relief, precise dose control, and a safer inhalation experience. Our innovative aerosol-release design delivers medical cannabis smoke in a controlled, repeatable way, free from the toxic compounds of traditional smoking. This means patients can trust each dose is consistent, measurable, and tailored. Benefit from fast onset, accurate adjustable dosing, reduced respiratory risk, and a platform built for clinical reliability. CondensaMed empowers patients with a delivery method that’s safer, smarter, and more reliable.
Our vision for healthier futures
CondensaMed began with a simple realisation: patients deserved better than imprecise or unsafe medical cannabis delivery. We saw a gap between therapeutic promise and practical reality. Our idea was to rethink inhalation as a medical-grade platform, respecting patient safety and supporting clinician confidence. Our bold dream is to make CondensaMed a new standard for medical cannabis inhalation, first in Australia, then globally. We envision a platform that enables predictable dosing, supports clinical research, and integrates seamlessly into regulated healthcare. Ultimately, CondensaMed aims to shift medical cannabis from workaround to world-class care, opening doors for precision, safe, inhaled therapies beyond cannabis.
"We build on evidence, optimise for patient outcomes, and innovate with purpose — setting a new bar for how medical cannabis can safely and consistently reach the people who need it."
The CondensaMed team